Corcept Therapeutics Incorporated (CORT) — Free Cash Flow Generation Index
Corcept Therapeutics Incorporated (CORT) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $38.40 Million represents 1% of operating cash flow ($38.45 Million). Explore Corcept Therapeutics Incorporated (CORT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Corcept Therapeutics Incorporated Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Corcept Therapeutics Incorporated across 11 annual periods. For the full cash flow conversion analysis, see Corcept Therapeutics Incorporated cash conversion from operations.
Annual Free Cash Flow Generation for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year Free Cash Flow Generation Index for Corcept Therapeutics Incorporated. Check CORT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $141.78 Million | $142.00 Million | $211.00K | ▲ +1.0% |
| 2024 | 0.99x | $195.90 Million | $198.07 Million | $2.17 Million | ▼ -1.0% |
| 2023 | 1.00x | $126.90 Million | $127.04 Million | $139.00K | ▲ +0.2% |
| 2022 | 1.00x | $119.91 Million | $120.32 Million | $413.00K | ▼ -0.1% |
| 2021 | 1.00x | $167.42 Million | $167.89 Million | $469.00K | ▲ +0.5% |
| 2020 | 0.99x | $150.73 Million | $151.97 Million | $1.24 Million | ▼ 0.0% |
| 2019 | 0.99x | $135.03 Million | $136.12 Million | $1.09 Million | ▼ -0.5% |
| 2018 | 1.00x | $115.37 Million | $115.67 Million | $298.00K | ▲ +0.4% |
| 2017 | 0.99x | $60.52 Million | $60.94 Million | $419.00K | ▲ +0.4% |
| 2016 | 0.99x | $18.20 Million | $18.39 Million | $194.00K | ▼ -0.5% |
| 2015 | 0.99x | $3.11 Million | $3.13 Million | $17.00K | — |